Israel - hebraisk - Ministry of Health

מדי פישר הנדסה ומדע (2002) בע"מ - רופא - עדשות להשתלה תוך עינית + טבעות לקופסת העין

Israel - hebraisk - Ministry of Health

דגש עיניים בע"מ - רופא - כלי עזר להחדרת העדשה לכיס בקרנית העין

Israel - hebraisk - Ministry of Health

kivema ltd. - כלל האוכלוסיה - תמיסות שטיפה והרטבה בתוך העין ומחוצה לה של עדשות מגע

Israel - hebraisk - Ministry of Health

אלפא-נטו בע"מ - רופא - שחזור דרכי דמעות ועינים + פלסטיקת העין

Israel - hebraisk - Ministry of Health

novartis israel ltd - moxifloxacin as hydrochloride - תמיסה לעין - moxifloxacin as hydrochloride 0.5 % - moxifloxacin - moxifloxacin - for the treatment of bacterial conjunctivitis caused by susceptible strains or organisms.

Israel - hebraisk - Ministry of Health

abbvie biopharmaceuticals ltd, israel - ciclosporin - תחליב לעין - ciclosporin 0.05 % - cyclosporin - cyclosporin - to increase tear production in patients whose tear production is presumed to be supressed due to ocular inflammation associated with keratoconjunctivitis sicca. increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.

Israel - hebraisk - Ministry of Health

rekah pharmaceutical industry ltd, israel - chloramphenicol - משחה לעין - chloramphenicol 5 % - chloramphenicol - chloramphenicol - for eye infections due to chloramphenicol susceptible microorganisms.

Israel - hebraisk - Ministry of Health

novartis israel ltd - tobramycin - משחה לעין - tobramycin 0.3 % - tobramycin - tobramycin - antibiotic for the treatment of eye infections caused by bacteria sensitive to tobramycin.

Israel - hebraisk - Ministry of Health

abic marketing ltd, israel - loteprednol etabonate; tobramycin - תרחיף לעין - tobramycin 3 mg/ml; loteprednol etabonate 5 mg/ml - tobramycin - tobramycin - zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.the particular anti-infect

Israel - hebraisk - Ministry of Health

novartis israel ltd - dexamethasone; neomycin as sulfate; polymyxin b sulfate - תרחיף לעין - dexamethasone 1.0 mg/ml; neomycin as sulfate 3,500 iu/ml; polymyxin b sulfate 6000 iu/ml - polymyxin b - polymyxin b - maxitrol is indicated in ocular inflammation when concurrent use of antimicrobial in judged necessary.